Sign in

CIK 0001701541

  • Non-accelerated filer
  • Smaller reporting company

Black Diamond Therapeutics, Inc.

Sign in to watch
Ticker
BDTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
814254660
Phone
+1 617-417-5868
Business address
245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
Former names
Aset Therapeutics, Inc.
  1. 4 Grant or award Director acquired 3,843 shares (grant or award)
  2. 4 Grant or award Director acquired 6,170 shares (grant or award)
  3. 4 Grant or award Director acquired 5,526 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 7,646 shares (grant or award)
  11. 4 Grant or award Director acquired 6,848 shares (grant or award)
  12. 4 Open-market sale 10% owner sold 5,784,292 shares at an average $2.07 ($11,997,749)
  13. 4 Grant or award PRESIDENT & CEO acquired 75,000 shares (grant or award)
  14. 4 Grant or award CHIEF MEDICAL OFFICER acquired 75,000 shares (grant or award)
  15. 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 75,000 shares (grant or award)
  16. 4 Grant or award Jones Erika acquired 75,000 shares (grant or award)
  17. 4 Grant or award Hatzis-Schoch Brent acquired 75,000 shares (grant or award)
  18. 4 Grant or award Director acquired 5,750 shares (grant or award)
  19. 4 Grant or award Director acquired 5,150 shares (grant or award)
  20. 4 Grant or award Director acquired 4,500 shares (grant or award)

Page 2 of 15 · 283 filings